Jeffrey Ulmer, PhD

During his 30-year career in vaccines R&D at Merck Research Laboratories, Chiron Corporation, Novartis Vaccines and GSK, Dr. Jeffrey Ulmer’s leadership roles and responsibilities have included: Platform Technology Leader (DNA, RNA vaccines), Project Leader (Tuberculosis, SARS), Department Head (Immunology & Cell Biology), US Site Head for Research, Global Function Head (External Research), Head, Preclinical R&D, and Program Head, Technical R&D. Dr. Ulmer received his Ph.D. in biochemistry from McGill University and completed his postdoctoral training in the laboratory of Nobel laureate Dr. George Palade in the Department of Cell Biology at Yale University School of Medicine. He has published over 200 scientific articles and is an inventor on 11 patents.